You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review

Article info

Article menu
XML
Haematology (incl blood transfusion)
Original research
Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review

Authors

  • Olivia S Costa Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USAEvidence-Based Practice Center, Hartford Hospital, Hartford, Connecticut, USA PubMed articlesGoogle scholar articles
  • William L Baker Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USAEvidence-Based Practice Center, Hartford Hospital, Hartford, Connecticut, USA PubMed articlesGoogle scholar articles
  • Yuani Roman-Morillo Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USAEvidence-Based Practice Center, Hartford Hospital, Hartford, Connecticut, USA PubMed articlesGoogle scholar articles
  • Kelly McNeil-Posey Health Economics and Outcomes Research, Portola Pharmaceuticals Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Belinda Lovelace Health Economics and Outcomes Research, Portola Pharmaceuticals Inc, South San Francisco, California, USA PubMed articlesGoogle scholar articles
  • C Michael White Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USAEvidence-Based Practice Center, Hartford Hospital, Hartford, Connecticut, USA PubMed articlesGoogle scholar articles
  • Craig I Coleman Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USAEvidence-Based Practice Center, Hartford Hospital, Hartford, Connecticut, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Craig I Coleman; Craig.Coleman{at}hhchealth.org
View Full Text

Citation

Costa OS, Baker WL, Roman-Morillo Y, et al
Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review
BMJ Open 2020;10:e040499. doi: 10.1136/bmjopen-2020-040499

Publication history

  • Received May 14, 2020
  • Revised October 5, 2020
  • Accepted October 18, 2020
  • First published November 5, 2020.
Online issue publication 
October 18, 2023
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.